Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Join the Waitlist How It Works FOXO4-DRI employs a sophisticated molecular approach to selectively eliminate senescent cells through targeted protein disruption
It works through a different mechanism than GHK-Cu: PDRN activates the A2A adenosine receptor, which triggers tissue regeneration, dampens inflammation, and supports the cellular metabolism of dermal cells
It came out in early 2024, and in June 2025, MuscleTech updated the branding and labeling to match the rest of the platform
The 2024 EVOLVE study reported that biologic-nave Crohns disease patients experienced similar 12-month effectiveness with either vedolizumab or infliximab
O/shot and P/shot are considered to be regenerative medicine therapy clinic Garland Rowlett Sunnyvale
US$ 22.82
US$ 24.69
US$ 22.35
US$ 23.85
US$ 27.06
